Immunotherapy Revolution: How the PD-1 Non-Small Cell Lung Cancer...

added blog Health

2025-12-23 08:41:49 -

Immunotherapy Revolution: How the PD-1 Non-Small Cell Lung Cancer Treatment Market is Turning a Terminal Diagnosis into a Manageable Disease

For decades, a diagnosis of advanced non-small cell lung cancer (NSCLC) was one of the most feared in medicine, with very few long-term survivors. However, the introduction of Programmed Death-1 (PD-1) inhibitors has completely changed the landscape of oncology. These drugs work by unmasking cancer cells that are trying to hide from the immune system, allowing the body's own T-cells to find and...

0 Comments 0 Shares 83 Views 0 Reviews